Farkouh Michael E, Aneja Ashish, Reeder Guy S, Smars Peter A, Lennon Ryan J, Wiste Heather J, Traverse Kay, Razzouk Louai, Basu Ananda, Holmes David R, Mathew Verghese
Mount Sinai School of Medicine, Cardiovascular Institute, New York, New York, USA.
Am J Cardiol. 2009 Aug 15;104(4):492-7. doi: 10.1016/j.amjcard.2009.04.007. Epub 2009 Jun 24.
The objective of this study was to determine short- and long-term cardiovascular outcomes in unselected patients with diabetes mellitus (DM) with acute ischemic chest pain (AICP). In patients with DM presenting to the emergency department with AICP, short-term cardiovascular outcomes remain discordant between trials and registries, whereas long-term outcomes are not well-described. A consecutive cohort of all residents of Olmsted County, Minnesota, presenting with AICP from January 1, 1985, to December 31, 1992, was followed for a median duration of 16.6 years. The primary outcome was long-term all-cause mortality. Other outcomes included a composite of death, myocardial infarction, stroke, and revascularization (major adverse cardiovascular and cerebrovascular events [MACCEs]) as well as heart failure (HF) events at 30 days and at a median of 7.3 years, respectively. Of the 2,271 eligible patients, 336 (14.8%) were classified with DM. The crude 30-day MACCE rate was 10.1% in patients with DM and 6.1% in those without DM (p = 0.007). HF events were more common in patients with DM at 30 days (9.8% vs 3.1%, p <0.001). At 7.3 years, patients with DM were more likely to experience MACCEs and HF events than those without DM (71.2% vs 45.1%, unadjusted hazard ratio 2.15%, 95% confidence interval 1.87 to 2.48, p <0.001, and 45.1% vs 18.2%, p <0.001, respectively). Over the follow-up period, 272 patients with DM (81.9%) died, compared with 936 (49.2%) without DM (p <0.001). In conclusion, DM is associated with a higher short-term risk for MACCEs and HF and a higher long-term risk for mortality in unselected patients with AICP. DM should be included as a high-risk variable in national acute coronary syndrome guidelines.
本研究的目的是确定未经过筛选的糖尿病(DM)合并急性缺血性胸痛(AICP)患者的短期和长期心血管结局。在因AICP就诊于急诊科的DM患者中,试验和登记处的短期心血管结局仍不一致,而长期结局则描述得不够充分。对1985年1月1日至1992年12月31日期间明尼苏达州奥尔姆斯特德县所有因AICP就诊的居民进行连续队列研究,随访时间中位数为16.6年。主要结局是长期全因死亡率。其他结局包括30天和中位数为7.3年时的死亡、心肌梗死、中风和血运重建的复合结局(主要不良心血管和脑血管事件[MACCEs])以及心力衰竭(HF)事件。在2271例符合条件的患者中,336例(14.8%)被归类为DM。DM患者30天的MACCE粗发生率为10.1%,非DM患者为6.1%(p = 0.007)。HF事件在DM患者30天时更常见(9.8%对3.1%,p <0.001)。在7.3年时,DM患者比非DM患者更有可能发生MACCEs和HF事件(分别为71.2%对45.1%,未调整风险比2.15%,95%置信区间1.87至2.48,p <0.001,以及45.1%对18.2%,p <0.001)。在随访期间,272例DM患者(81.9%)死亡,而非DM患者为936例(49.2%)(p <0.001)。总之,在未经过筛选的AICP患者中,DM与MACCEs和HF的短期风险较高以及死亡率的长期风险较高相关。DM应作为高危变量纳入国家急性冠状动脉综合征指南。